688238 Obio Technology
- 6.43
- -0.14-2.13%
Obio Technology News
Announcement on the expiration of the shareholders\' holdings reduction plan and changes in equity of 1%
Shareholding by shareholders has not been reduced by half of the shareholding reduction period, and progress in shareholding reduction is announced.
Shareholders' share reduction plan announcement
Announcement on the fulfillment of the exercise conditions for the second exercise period of the 2021 Stock Options Incentive Plan
Audit opinion of the Supervisory Board on the list of eligible incentive recipients for the second exercise period of the 2021 Stock Options Incentive Plan
Announcement on Cancelling Part of the 2021 Stock Options Incentive Plan
Legal Opinion of Shanghai Jinmao Law Firm on the Fulfilment of Enforcement Conditions and Cancellation of Some Stock Options in the Second Exercise Period of Heyuan Biotechnology (Shanghai) Co., Ltd. 2021 Stock Option Incentive Plan
Announcement on the 2023 Profit Distribution Plan
Announcement on the initial public offering, strategic placement, listing and circulation of restricted shares
Announcement on the listing and circulation of some restricted shares in the initial public offering
Announcement on the listing and circulation of some restricted shares in the initial public offering
Announcement of the expiration of the shareholders\' holdings reduction plan and changes in equity of 1%
Announcement on the listing and circulation of some restricted shares in the initial public offering
Announcement on the listing and circulation of some restricted shares in the initial public offering
Announcement on the reduction of shareholders\' holdings by more than half of the time and the progress of stock holdings reduction
Announcement of the first exercise option results and share changes in the 2021 Stock Options Incentive Plan
Announcement of the results of shareholders\' share holdings
Announcement on adjusting the exercise price and number of options for the 2021 Stock Option Incentive Plan
Legal Opinion of Shanghai Jinmao Law Firm on Heyuan Biotechnology (Shanghai) Co., Ltd. adjusting the exercise price and number of options under the 2021 Stock Option Incentive Plan
Announcement on the listing and circulation of some restricted shares in the initial public offering
Analysis
Price Target
No Data
No Data